scispace - formally typeset
Journal ArticleDOI

Intermittent Acute Porphyria — Demonstration of a Genetic Defect in Porphobilinogen Metabolism

Reads0
Chats0
TLDR
In a family with intermittent acute porphyria five affected members were found to have decreased erythrocyte uroporphyrinogen I (URO)-synthetase activity, when compared to unaffected members.
Abstract
In a family with intermittent acute porphyria (IAP) five affected members were found to have decreased erythrocyte uroporphyrinogen I (URO)-synthetase activity, when compared to unaffected...

read more

Citations
More filters
Journal ArticleDOI

5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.

TL;DR: Studies have shown that a higher accumulation of ALA‐derived PpIX in rapidly proliferating cells may provide a biologic rationale for clinical use of ALa‐based PDT and diagnosis, however, no review updating the clinical data has appeared so far.
Journal ArticleDOI

An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.

TL;DR: It is proposed that porphyria cutanea tarda results from the combination of an inherited defect in uroporphyrinogen decarboxylase and an acquired factor, usually siderosis associated with alcoholic liver disease.
Journal ArticleDOI

Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria

TL;DR: To study the pathogenesis of the neurologic symptoms of AIP, Pbgd-deficient mice are generated by gene targeting and reveal decreased motor function and-histo-pathological findings include axonal neuropathy and neurologic muscle atrophy.
Journal ArticleDOI

The enzymatic defect in variegate prophyria. Studies with human cultured skin fibroblasts.

TL;DR: Fecal protoporphyrin is increased in patients with variegate porphyria, even during clinical remission, suggesting an enzymatic defect in the terminal portion of the heme biosynthetic path.
Journal ArticleDOI

Molecular Epidemiology and Diagnosis of PBG Deaminase Gene Defects in Acute Intermittent Porphyria

TL;DR: The evaluation of the efficiency of the standard PBG deaminase enzymatic screening method for gene-carrier detection indicated 95% of concordancy with the molecular-based diagnosis.
References
More filters
Journal Article

Protein Measurement with the Folin Phenol Reagent

TL;DR: Procedures are described for measuring protein in solution or after precipitation with acids or other agents, and for the determination of as little as 0.2 gamma of protein.
Journal ArticleDOI

THE OCCURRENCE AND DETERMINATION OF δ-AMINOLEVULINIC ACID AND PORPHOBILINOGEN IN URINE

TL;DR: A sensitive calorimetric method for the quantitative determination of SAL is described and 6AL has been found in urine of a patient with acute porphyria and also in normal urine.
Journal ArticleDOI

The Induction in Vitro of the Synthesis of δ-Aminolevulinic Acid Synthetase in Chemical Porphyria: A Response to Certain Drugs, Sex Hormones, and Foreign Chemicals

TL;DR: Evidence is presented that the control of ALA synthetase in the liver is by feedback repression in which heme may be the corepressor and no feedback inhibition was found.
Journal ArticleDOI

δ-Aminolevulinic Acid Synthetase II. INDUCTION IN RAT LIVER

TL;DR: The administration of actinomycin D or 5-fluorouracil to rats previously treated with allylisopropylacetamide results in a rapid decline of the hepatic levels of induced δ-aminolevulinic acid synthetase, which suggests that the turnover of the messenger RNA for hepatic δ, £2,000-3,000 acids is considerably more rapid than the bulk of rat liver messenger RNA.
Related Papers (5)